[go: up one dir, main page]

ES2139570T3 - Sistema transdermico mejorado para la aplicacion de compuestos farmacologicamente activos bajo condiciones de ph controladas. - Google Patents

Sistema transdermico mejorado para la aplicacion de compuestos farmacologicamente activos bajo condiciones de ph controladas.

Info

Publication number
ES2139570T3
ES2139570T3 ES90917612T ES90917612T ES2139570T3 ES 2139570 T3 ES2139570 T3 ES 2139570T3 ES 90917612 T ES90917612 T ES 90917612T ES 90917612 T ES90917612 T ES 90917612T ES 2139570 T3 ES2139570 T3 ES 2139570T3
Authority
ES
Spain
Prior art keywords
active compounds
improved
pharmacologically active
conditions
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90917612T
Other languages
English (en)
Inventor
Arun Rajaram Gupte
Uwe Rohr
Bernd Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Application granted granted Critical
Publication of ES2139570T3 publication Critical patent/ES2139570T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA INVENCION SE REFIERE A UNA APLICACION TRANSDERMAL MEJORADA DE COMPUESTOS FARMACOLOGICAMENTE ACTIVOS.
ES90917612T 1989-12-01 1990-11-29 Sistema transdermico mejorado para la aplicacion de compuestos farmacologicamente activos bajo condiciones de ph controladas. Expired - Lifetime ES2139570T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939703A DE3939703C2 (de) 1989-12-01 1989-12-01 Verbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen

Publications (1)

Publication Number Publication Date
ES2139570T3 true ES2139570T3 (es) 2000-02-16

Family

ID=6394557

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90917612T Expired - Lifetime ES2139570T3 (es) 1989-12-01 1990-11-29 Sistema transdermico mejorado para la aplicacion de compuestos farmacologicamente activos bajo condiciones de ph controladas.

Country Status (20)

Country Link
EP (1) EP0456792B1 (es)
JP (1) JPH04506811A (es)
KR (1) KR0143549B1 (es)
AT (1) ATE185492T1 (es)
AU (1) AU637861B2 (es)
CA (1) CA2046337C (es)
DE (2) DE3939703C2 (es)
DK (1) DK0456792T3 (es)
ES (1) ES2139570T3 (es)
FI (1) FI107707B (es)
GR (1) GR3032175T3 (es)
HU (1) HU206993B (es)
IE (1) IE904322A1 (es)
IL (1) IL96506A (es)
NO (1) NO302156B1 (es)
NZ (1) NZ236280A (es)
PT (1) PT96045B (es)
RU (1) RU1834665C (es)
WO (1) WO1991007998A1 (es)
ZA (1) ZA909624B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
JP3526887B2 (ja) * 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
ATE310539T1 (de) 2001-12-21 2005-12-15 Coloplast As Artikel zur wundbehandlung
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4830856A (en) * 1987-01-27 1989-05-16 Peppers James M Chelation product
ATE101511T1 (de) * 1988-08-02 1994-03-15 Ciba Geigy Ag Mehrschichtiges pflaster.
AU4745390A (en) * 1988-12-01 1990-06-26 Schering Corporation Compositions for transdermal delivery of estradiol
DE3843557A1 (de) * 1988-12-23 1990-06-28 Beiersdorf Ag Transdermales therapeutisches system zur verabreichung von clenbuterol

Also Published As

Publication number Publication date
DE3939703C2 (de) 1998-07-02
ATE185492T1 (de) 1999-10-15
NO912985L (no) 1991-07-31
HU912638D0 (en) 1992-01-28
ZA909624B (en) 1992-08-26
GR3032175T3 (en) 2000-04-27
IE904322A1 (en) 1991-06-05
NO302156B1 (no) 1998-02-02
DE3939703A1 (de) 1991-06-06
FI913645A0 (fi) 1991-07-31
DK0456792T3 (da) 2000-04-03
AU6875791A (en) 1991-06-26
CA2046337C (en) 2004-05-25
DE59010885D1 (de) 1999-11-18
CA2046337A1 (en) 1991-06-02
KR920700704A (ko) 1992-08-10
NO912985D0 (no) 1991-07-31
IL96506A (en) 1996-01-19
IL96506A0 (en) 1991-08-16
NZ236280A (en) 1994-06-27
WO1991007998A1 (de) 1991-06-13
RU1834665C (ru) 1993-08-15
EP0456792B1 (de) 1999-10-13
AU637861B2 (en) 1993-06-10
EP0456792A1 (de) 1991-11-21
FI107707B (fi) 2001-09-28
PT96045B (pt) 1998-01-30
HUT59615A (en) 1992-06-29
PT96045A (pt) 1991-09-13
HU206993B (en) 1993-03-01
JPH04506811A (ja) 1992-11-26
KR0143549B1 (ko) 1998-07-01

Similar Documents

Publication Publication Date Title
BR8600840A (pt) Polimerizacao catalisada por oxianion
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
NO893400D0 (no) Hiv protease inhibitorer egnet for behandling av aids.
NO164092C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrebaserte kollagenaseinhibitorer.
FI882819L (fi) Analogiamenetelmä medetomidiinin terapeuttisesti aktiivisen d-isomeerin valmistamiseksi
IT1151727B (it) Procedimento per il trattamento di una formazione sotterranea con una composizione di cemento acquosa
NO843002L (no) Vandig loesning inneholdende en lipid-loeselig farmasoeytisk substans
FR2309281A1 (fr) Installation pour la destruction d'ordures, notamment pour hopitaux
MX9203768A (es) Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a.
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
ES2139570T3 (es) Sistema transdermico mejorado para la aplicacion de compuestos farmacologicamente activos bajo condiciones de ph controladas.
FR2598081B1 (fr) Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
NO882614L (no) Anvendelse av jordalkalisater av eterkarboksylsyrer som katalysatorer for alkoksylering.
NO165674C (no) Anvendelse av et belegg av slaggsemtentbetong for aa beskytte betongkonstruksjoner.
IT9067649A0 (it) Procedimento di produzione di formulazioni enzimatiche acquose
NO871190D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider.
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
FI861557A7 (fi) Menetelmä farmakologisesti aktiivisten fosfiiniyhdisteiden valmistamiseksi.
ATE60779T1 (de) N-glykolylneuraminsaeurederivat.
ES2178080T3 (es) Procedimiento para la preparacion de derivados de alcoxi-o ariloxi-pirazina.
NO162642C (no) Anvendelse av hydroksymetansulfonsyre som virksom bestanddel i et sanitaermiddel.
FI853089A7 (fi) Menetelmä farmakologisesti aktiivisten yhdisteiden syntetisoimiseksi ja tämäm synteesin välituotteet.
SE9901340D0 (sv) Novel process
SU1467956A1 (ru) Метиловый эфир 2-дифенилметилиденгидразино-4-оксо-4-п-толил-2-бутеновой кислоты, проявляющий антидепрессивную активность
SU1392844A1 (ru) 2,4-Динитро-6-вторбутилфениловый эфир 4-бромбензойной кислоты, обладающий акарицидным действием

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 456792

Country of ref document: ES